mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.003 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.003 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.003 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.003 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.003 |
mRNA |
Panobinostat |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.004 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.004 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.005 |
mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.005 |